RepRegen™ Ltd. (Formerly Known as BioCeramic Therapeutics)'s Chief Science Officer, Dr. Molly Stevens, is Named One of the Top-10 Scientists Under the Age of 40 in Britain

LONDON--(BUSINESS WIRE)--RepRegen™, the ‘smart biomaterials’ company, announced today that its Chief Science Officer, Molly Stevens, Ph.D., has been named one of the top-10 most important scientists under the age of 40 in Britain by The Times’ Eureka 100, “a new guide to the 100 most important contemporary figures in British science and engineering.”